Clinical Trial Update: Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating autologous cytokine-induced killer cell adoptive immunotherapy for acute myeloid leukemia and myelodysplastic syndromes has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Autologous cytokine-induced killer cell adoptive immunotherapy (cytokine-induced killer cells)

Snippet

Sponsor: Singapore General Hospital | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, High Grade | Phase 1, Phase 2 | Status: COMPLETED